Journal
/
Bioingeniería
/
Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology
JoVE Revista
Bioingeniería
Author Produced
This content is Free Access.
JoVE Revista Bioingeniería
Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology

Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology

7,060 Views

•

10:41 min

•

January 23, 2021

DOI:

10.3791/61962-v

DOI:
10.3791/61962-v

•

10:41 min
January 23, 2021

•

11 Views
,
1University of Newcastle, 2University of Sydney, 3Kolling Institute of Medical Research,Royal North Shore Hospital, 4University of Technology, Sydney

Summary

Automatically generated

This protocol aims to fabricate 3D cardiac spheroids (CSs) by co-culturing cells in hanging drops. Collagen-embedded CSs are treated with doxorubicin (DOX, a cardiotoxic agent) at physiological concentrations to model heart failure. In vitro testing using DOX-treated CSs may be used to identify novel therapies for heart failure patients.

Explore More Videos

Cardiac SpheroidsIn VitroHuman Heart PathophysiologyCardiac MyocytesCardiac FibroblastsCardiac Endothelial CellsDrug Toxicity AssaysDoxorubicinCardiomyocytesCell CultureHanging DropSpheroid Formation

Read Article

Cite this Article

Sharma, P., Gentile, C. Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology. J. Vis. Exp. (167), e61962, doi:10.3791/61962 (2021).

Download .ris file

Copy

Share Video

.

Copy